Glipxen 5 

Presentation:Glipxen 5 is presented as tablets, each containing 5mg of linagliptin.The tablets are usually available in blister packs. The appearance (shape, color) of the tablets may vary depending on the manufacturer in Bangladesh (e.g., Beacon Pharmaceuticals PLC).

Indications:Glipxen (linagliptin) is indicated in adults with type 2 diabetes mellitus to improve glycemic control:  

• As monotherapy: in patients inadequately controlled by diet and exercise alone and forwhom metformin is inappropriate due to intolerance or contraindications. 
• As combination therapy: in combination with metformin, or with a sulfonylurea and metformin, when diet and exercise plus the single or dual therapy do not provide adequate glycemic control.

Dosage and Administration:The recommended dose of Glipxen is 5 mg once daily.It can be taken with or without food at any time of the day.  

• Monotherapy or combination with metformin: The 5 mg daily dose should be maintained.
• Combination with a sulfonylurea: A lower dose of the sulfonylurea may be considered to reduce the risk of hypoglycemia.
• Patients with renal impairment:No dose adjustment of Glipxen is required.  

Follow your doctor's specific instructions regarding the dosage and timing of Glipxen.

Side Effects:Common side effects reported with linagliptin alone include nasopharyngitis.When used in combination with other antidiabetic agents, the side effect profile may differ:

• With metformin and sulfonylurea: Hypoglycemia, nasopharyngitis, cough, and pancreatitis have been reported.

Tell your doctor promptly if you experience any unusual or severe side effects.

Precautions:Glipxen (linagliptin) is contraindicated in patients with a history of hypersensitivity reaction to linagliptin or any of the excipients.  

Caution should be exercised when Glipxen is used in combination with sulfonylureas, as it may increase the risk of hypoglycemia.A dose reduction of the sulfonylurea may be considered.

Inform your doctor about all other medications you are taking, including herbal supplements, as there may be potential drug interactions.

The safety and efficacy of Glipxen in children under 18 years have not been established.

Use during pregnancy should only occur if clearly needed, and the potential benefits outweigh the risks to the fetus. It is not known if linagliptin is excreted in human breast milk; caution should be exercised when administered to a nursing woman.

Storage:Store Glipxen tablets in a dry place, away from light and heat.Keep out of reach of children.

Important Note: This information is for general knowledge and informational purposes only, and does not substitute professional medical advice. Always consult your doctor or pharmacist for specific instructions and guidance regarding your medication. They can assess your individual medical condition and provide the most appropriate advice.